The Mikko Rantanen trade undoubtedly ranks among the biggest in the salary cap era, but maybe recency bias plays a role in ...

Stem cell therapies can be effective for treating discogenic low back pain, according to a study published in the January 2025 issue of the International Journa ...

After five years of debilitating pain and multiple failed surgeries, an Indiana woman finally found relief through a groundbreaking augmented reality spine procedure performed at Northwestern Medicine ...

The drug, Journavx by Vertex Pharmaceuticals, blocks pain signals to the brain, making it nonaddictive. The Food and Drug ...

U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated ...

On Jan. 28, Stryker Corp. announced plans to sell its U.S. spinal implant business to investment firm Viscogliosi Brothers. Though Stryker has a major share in the U.S. spine and orthopedic market, ...

Advances in technology have increased ASCs' ability to perform these procedures, as they are increasingly approved for outpatient settings. The use of robots in total knee arthroplasty increased ...

Apple Inc. (AAPL) reported its Q4 fiscal year 2024 earnings, revealing a significant miss on both earnings per share (EPS) and revenue forecasts. The company posted an EPS of $1.64 and revenue of $94.